chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Incorrect route of drug administration, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male with environmental allergies, heart murmur and no known drug reactions/allergies who on 05-APR-2000 was vaccinated with a 0.5 mL IM dose of Varivax (lot # 632368/1460J). Concomitant therapy included CLARITIN. On 16-MAY-2006 the patient developed varicella. The patient presented to the office on 19-MAY-2006 with a rash of 30-40 lesions on his abdomen and back. No laboratory tests were performed. At the time of the report, the patient's varicella persisted. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a nurse in a physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot# not reported). Subsequently, the patient developed a mild case of chickenpox, 8-15 lesions. The patient's outcome was not reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse in a physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot# not reported). Subsequently the patient developed a mild case of chicken pox, 8-15 lesions. The patient's outcome was not reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a nurse in a physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot# not reported). Subsequently the patient developed a mild case of chicken pox, 8-15 lesions. The patient's outcome was not reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a nurse in a physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot# not reported). Subsequently the patient developed a mild case of chicken pox, 8-15 lesions. The patient's outcome was not reported.
Sex: U
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a nurse in physician's office concerning a pediatric patient who may have been vaccinated with a dose of Varivax (lot# not reported). Subsequently the patient developed a mild case of chicken pox, 8-15 lesions. The patient's outcome was not reported. Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site rash
Clinical narrative: Information has been received from a physician concerning a 10-year-old male with no medical history or allergies who on 09-MAY-2006 was vaccinated SC with a 0.5 mL dose of Varivax (Lot #652081/0942R). There was no concomitant therapy. The physician reported that on approximately 11-MAY-2006 the patient developed an approximately 10 cm rash in diameter at the injection site. No other symptoms were noted. Unspecified medical attention was sought, but no laboratory/diagnostic tests were performed. At the time of this report, the patient's rash persisted. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Nasal congestion, Pyrexia, Rash erythematous, Rash papular
Clinical narrative: Information has been received from a health professional concerning an 8 year old male, with no medical history and no allergies, who on 07-FEB-1998 was vaccinated with a 0.5 ml subcutaneous dose of Varivax (Lot# 624441/1105E). There was no concomitant medication. It was reported by the patient's mother to the reporter that the patient had a rash of erythematous papules in the past, on an unspecified date. The patient presented on 11-MAY-2006 to the practice with a similar rash of erythematous papules on his trunk and head, beginning on 10-MAY-2006. It was noted that there was some crusting of the papules, but they were not fluid filled. The patient was also experiencing a mild fever and congestion. At the time of the report the patient was recovering. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a nurse practitioner concerning a 7 year old male who on 10-APR-2000 was vaccinated with a dose of Varivax. On 19-MAY-2006, the patient developed five or six lesions. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a female patient who was vaccinated with Varivax. The patient has recently, in approximately April 2006, been diagnosed with breakthrough chicken pox. It was reported that there was a swab of her lesions that diagnosed the chicken pox. The patient's brother (WAES 0605USA00024) was also diagnosed with chicken pox. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Secondary transmission, Varicella
Clinical narrative: Information has been received from a physician concerning a father, who was naive to chickenpox, who's 13 month old daughter who on 16-MAR-2006 was vaccinated with a dose of Varivax (Lot# 649999/0910R). It was reported that the patient developed chickenpox, described as vaccine strain, and had since recovered. It was noted that the father will be having samples tested for adenosine deaminase levels. The patient's daughter experienced a reaction following vaccination with Varivax (WAES# 0604USA03984). Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 15 year old female who "about 6 years ago" in approximately 2000 was vaccinated with a 0.5 mL SC dose of Varivax. Subsequently "about six years ago" in approximately 2000 the patient experienced breakthrough chickenpox. Unspecified medical attention was sought. No laboratory diagnostic tests were performed. Subsequently, the patient recovered. There was no product quality complaint involved. It was reported that the patient's brothers (WAES#'s 0607USA04565 and 0607USA04566) developed similar adverse experience after vaccination with Varivax. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning an 18 year old female with high cholesterol and no allergies who in 1998 was vaccinated with a first and second dose of Varivax. Concomitant therapy included Lipitor and Accutane. On 01-MAY-2006, the patient had a negative titer. Unspecified medical attention was sought. At the time of the report, the patient had "not recovered." A product quality complaint was not involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 12-month-old female who on 04-MAY-2006 was vaccinated with a dose of Varivax (lot# 652804/0263F). Concomitant vaccinations included a dose of MMR and a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown). Subsequently, on an unspecified date, the patient developed a minimum of 50 pock marks, sought unspecified medical attention and was diagnosed with chickenpox. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 32.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a physician concerning a 32-year-old female who about 10 years ago, in approximately 1996, was vaccinated with a dose of Varivax. Subsequently, the patient recently underwent a titer that did not show seroconversion. Unspecified medical attention was sought. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 17 year old female who in 1999 was vaccinated "twice" with a 0.5 ml dose of Varivax. On 24-MAY-2006 it was reported that "last week" the patient had "zoster on her forehead". Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health care facility concerning a 37 month old white male who on 20-APR-2004 at 14:@0 was vaccinated in the deltoid with a first dose of Varivax (lot # 647270/1103N). On 22-MAY-2006 at 14:00 the patient broke out in chickenpox. At the time of the report, the patient had not yet recovered. Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 6-year-old white male who on 18-JUL-2001 at 3:55 pm was vaccinated in the deltoid with a first dose of Varivax (Lot # 637371/1609K). ON 22-MAY-2006 at 2:00 pm the patient developed chickenpox on the trunk of the body, and on the bottom and axillary areas. The patient's chickenpox persisted. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received concerning a 16 month old white male who on 01-MAR-2006 at 9:30 am was vaccinated in the deltoid with a first dose of Varivax (lot # 649738/0120R). There was no illness after vaccination. On 22-MAY-2006 at 2 pm the patient broke out in chickenpox. At the time of the report the patient had not recovered. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a pharmacist student concerning an adult patient who was vaccinated with Varivax. Subsequently the patient experienced varicella breakthrough. Patient outcome was not reported. Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/16/2007. Information has been received from a pharmacist student concerning an adult patient who was vaccinated with VARIVAX. Subsequently the patient experienced varicella breakthrough. Patient outcome was not reported. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an elementary school age female who was vaccinated with a single dose of Varivax. The physician reported that the patient subsequently developed a moderate case of chickenpox. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a female patient who on 14-NOV-2003 was vaccinated with a dose of Varivax. On 22-MAY-2006, the patient broke out with a moderate case of chickenpox. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning an 8 year old male with no allergies or medical history who, about 7 years ago, in approximately 1999, was vaccinated with a dose of Varivax. There was no concomitant medication. Within the past few days, on approximately 22-MAY-2006, the patient developed a mild case of chickenpox. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 4 year old male who was vaccinated with a single dose of Varivax. Subsequently the patient broke out with chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. The patient's three brothers experienced chickenpox following vaccination with Varivax (WAES# 0606USA01456, 0606USA01457, and 0606USA01458). Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a person at a physician's office concerning a 7-year-old female who on 23-SEP-1999 at 10:30am was vaccinated in the deltoid with a second dose of Varivax (lot# 628027/1257H). On 23-MAY-2006 at 15:47 pm the patient broke out all over in chickenpox. Unspecified medical attention was sought. At the time of this report the patient's chickenpox continued. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Secondary transmission, Varicella
Clinical narrative: Information has been received from an unknown source concerning an 11-year-old white female with no pre-existing allergies, birth defects or medical conditions, who on an unspecified date in December 1995, was vaccinated with a second dose of Varivax. There was no illness at the time of vaccination. There was no concomitant medication. On 14-MAY-2006 the patient developed a mild case of chickenpox. It was noted that she contracted them from her father who had shingles. She had a couple dozen spots on her face, back and stomach that were not very itchy. It was unspecified if the patient sought medical attention. No outcome was reported. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature, Pruritus, Rash, Skin lesion, Varicella
Clinical narrative: Information has been received from a licensed practical nurse concerning an 8 year old female with no allergies or medical history who on 15-JAN-1999 was vaccinated with a dose of Varivax (lot # 628036/1251H). On 24-MAY-2006, the patient began to develop a rash. She presented to the physician's office on 26-MAY-2006 and was noted to have more itchy lesions all over her body. She was afebrile. The child's mother had been treating her with BENADRYL 25 mg daily. No diagnostic laboratory tests were performed. At the time of the report, the patient had not recovered. It was also noted that the patient's sister had the chickenpox first, but the reporter was unsure if the sibling had ever been vaccinated with Varivax. A product quality complaint was not involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: PNC, VARCEL
Symptoms: Body temperature increased, Pyrexia, Rash
Clinical narrative: Information has been received from a women at a pediatrician's office concerning a 24-month-old Caucasian female with a history of assymetric lung fields, who on 05-MAY-2005 was vaccinated subcutaneously in the right thigh with a first dose of Varivax (lot # "0457P"). Concomitant vaccination given on the same day included a fourth dose of PREVNAR (lot# A57561F) given intramuscularly in the left thigh. There was no illness at the time of vaccination. On 14-MAY-2006 the patient developed a fever of 101 degrees Fahrenheit and rash on her legs, arms, head, chest and back. The patient was treated with TYLENOL. No medical attention was sought. The outcome was unknown at the time of this report. Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a physician concerning a 10 year old male who was vaccinated with a dose of Varivax. "Last week", on approximately 23-MAY-2006, the patient developed over 100 lesions over his body. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a registered (RN) concerning a 9-year-old female who on 05-DEC-1997 was vaccinated SC in the right arm with a 0.5 mL first dose of Varivax (Lot #622625/0085E). The RN reported that on 17-MAY-2006, the patient developed less than 50 lesions. Unspecified medical attention was sought, but no treatment was required. By 24-MAY-2006, the patient had recovered and returned to school. No additional information is available.
Age: 1.4
Sex: F
Vaccine: VARCEL
Symptoms: Blood immunoglobulin G normal, Blood immunoglobulin M, Rash maculo-papular, Rash vesicular, Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 5-year-old female with mild asthma and eczema and no drug reactions / allergies who on 08-JUN-2002 was vaccinated SC with a 0.5 mL dose of Varivax (Lot # 639681/0963L). There was no concomitant medication. ON 22-MAY-2006, the patient developed lesions similar to lesions of chickenpox and also poison ivy. Her lesions were located all over her body. Multiple lesions were described as blister-like, and other lesions were described as maculopapular. The patient was treated empirically with acyclovir and hydroxyzine. The patient did not have systemic symptoms, and she was afebrile. Lab tests included: IgG and IgM. Both were negative. The outcome was reported as not recovered. Unspecified medical attention was sought. No further information was available. There was no product quality complaint. The reporter considered the events to be other important medical events. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster, Secondary transmission
Clinical narrative: Information has been received from a physician concerning a parent of a pediatric patient (WAES# 0605USA01775) who was vaccinated with a dose of Varivax. Subsequently the parent developed herpes zoster while their child was experiencing breakthrough varicella. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a pediatric patient who was vaccinated with a dose of Varivax. Subsequently the patient experienced breakthrough varicella. There was no product quality complaint involved. It was reported that the patient's parent (WAES # 0605USA05217) experienced herpes zoster while the patient was experiencing breakthrough varicella. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster, Secondary transmission
Clinical narrative: Information has been received from a physician concerning a parent of a pediatric patient (WAES# 0605USA05216) who was vaccinated with a dose of Varivax. Subsequently the parent developed herpes zoster while their child was experiencing breakthrough varicella. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 5-year-old female with no pre-existing allergies, birth defects, or medical conditions who on 10-SEP-2001 was vaccinated SC with a second dose of Varivax (Lot # 638811/0498L). There was no concomitant medication. There was no illness at the time of vaccination. On 25-APR-2006 the patient developed skin eruptions "looking like chickenpox". There were less than 50 lesions. No fever was noted. The patient recovered on 28-APR-2006. There were no relevant diagnostic tests or laboratory data. No additional information is expected.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old female with no known history who on 28-MAR-2000 was vaccinated SC with a first dose of Varivax (lot # 632371/1464J). There was no illness at the time of vaccination. On 23-MAY-2006 the patient developed a chickenpox like rash. On 24-MAY-2006 the patient's mother called the physician's office. The patient had <50 lesions on her body and no fever was noted. On 26-MAY-2006 the patient recovered. No further information is expected.
Age: 1.5
Sex: F
Vaccine: DTP, IPV, VARCEL
Symptoms: Pyrexia, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning an 11 year old female with asthma who on 26-APR-1996 was vaccinated subcutaneously with a 0.5 mL dose of Varivax (Lot# unknown). Concomitant vaccinations included a dose of poliovirus (manufacturer unknown) and a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid. On 24-MAR-2006 the patient experienced high fever for four days, and moderate to severe breakthrough all over the body. Acyclovir was given to help with the lesions. Subsequently, on 31-MAY-2006 the patient recovered. No product quality complaint was involved. Additional information has been requested.
Age: 1.4
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 10 year old male, with no medical history and no known drug reactions/allergies reported, who on 25-MAR-1997 was vaccinated with only one dose of Varivax. There was no concomitant medication. The nurse reported a breakthrough of chickenpox in child vaccinated on 25-MAR-1997. The original vaccination was not in this office and notes did not indicate a lot #, dose, route of administration. On 29-MAY-2006 the patient contacted the doctor for rash on torso, face, extremities of less than 25 lesions. The physician diagnosed as breakthrough chickenpox. No fever noted and patient left the office not in distress, but will be followed. No product quality complaint was involved. Additional information has been requested
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from an office manager, via a company representative, concerning a patient (age and gender unknown), with unknown medical history and unknown drug reaction/allergies, who on an unspecified date was vaccinated (route unknown) with a dose of Varivax (Lot # unknown). The office manager reported that on 31-MAY-2006 that the patient experienced "a breakthrough". The patient's status was not reported. No product quality complaint was involved. Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse, via a mother of a consumer, concerning a 6 year old male, with unknown medical history and no known drug reactions/allergies reported, who on 16-NOV-2000 was vaccinated (route unknown) with a dose of Varivax (Lot # unknown). The patient was treated with acetaminophen (TYLENOL) and calamine lotion. The nurse reported that she received a call from the patient's mother. The mother stated that her son has "breakthrough chicken pox". The patient received varicella virus vaccine at another institution on 16-NOV-2000. It was reported that on 26-MAY-2006 the patient started with a fever and spots appearing on Saturday (27-MAY-2006). The spots appeared in scalp and generalized rash on body. The patient's mother would not bring the patient to the office for an examination. The amount and extent of spots were not reported. No product quality complaint was involved. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old male who in approximately 2002, "at age 1" was vaccinated with a 0.5mL dose of Varivax. On approximately 25-MAY-2006 the patient broke out with chickenpox. He had approximately 20 lesions. Unspecified medical attention was sought. At the time of this report, the patient was recovering. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a consumer concerning her daughter who in approximately September 2003, was vaccinated with a dose of Varivax. There was no concomitant medication. Subsequently the patient developed shingles on her left side. It was reported that there was no pain, itching or fever. The patient was seen in the physician's office and prescribed an anti-viral topical cream. There were no diagnostic or laboratory tests. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a healthy 34 year old female with allergies to Penicillin and cephalexin (KEFLEX), who on 07-APR-2006 was vaccinated in her left arm (route unknown) with a dose of Varivax (Lot # 652552/0022F). The doctor reported that the mother requested to be vaccinated prior to volunteer work at her child's preschool. Subsequently, on 24-APR-2006, 19 days after vaccination, the patient experienced a single case of generalized varicella eruption. She was treated with acyclovir (ZOVIRAX). At the time of the report, the patient was recovering without incident. Additional information received indicated that the patient was recovering without incident with acyclovir (ZOVIRAX) treatment and it was reported that the patient recovered. No further information is available.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 4 year old male, with no known drug reaction allergies, who on 06-JUN-2001 was vaccinated (route unknown) with a 0.5 mL dose of Varivax (Lot # 635453/0756K). On 05-MAY-2006 the patient developed a mild case of chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Herpes zoster, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 23 year old female, with no medical history and no allergies, who on 14-APR-2006 was vaccinated (route unknown) with a first dose in the left arm of Varivax (Lot # 650235/1110R). There was no concomitant medication. There was no illness at the time of vaccination and no adverse events following prior vaccination. On 24-APR-2006 the patient developed a scattered maculopapular rash, bilateral, on her upper arms, trunk, back, shoulders, and scalp with pruritus. There was no oozing, drainage, fever, or diarrhea. The patient was seen by a company physician and diagnosed with varicella. She was treated with an over the counter antihistamine (unspecified). Subsequently, the patient fully recovered on an unspecified date. The lab diagnostic studies performed indicated that the patient had a titer prior to vaccination. No product quality complaint was involved. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a male with no adverse drug reaction (ADR), who on 25-APR-2003 was vaccinated by injection with a 0.5 ml, dose of Varivax. There was no concomitant medication. Subsequently the patient recently developed a mild case of chicken pox-10 to 20 lesions. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse practitioner (NP) and a registered nurse (RN) concerning a 7-year-old male student with asthma, allergic rhinitis, a possible watermelon allergy and no known drug allergies (NKDA) who on 23-AUG-1999 was vaccinated SC in the left leg with the first 0.5 mL dose of Varivax (Lot #630409/0297J). There was no illness at the time of vaccination. Concomitant therapy included loratadine (CLARITIN), montelukast Na (MSD) and budesonide (RHINOCORT). It was reported that on 30-MAY-2006, the patient developed breakthrough chickenpox characterized by about 50 small pustules with erythematous base on his trunk, chest, back and thighs. Some itching was noted and the patient was afebrile. On 01-JUN-2006, the patient was seen in the physician's office and was treated with diphenhydramine HCl (BENADRYL) and oat (AVEENO BATH). No laboratory/diagnostic tests were performed. Subsequently, the patient's chickenpox resolved. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a student (patient) who in the past was vaccinated with Varivax. Subsequently in the past few weeks, the patient developed chicken pox. It was reported, the patient was in grade one. The patient sought  unspecified medical attention. The nurse reported that the physician have reported this to the state health department. At the time of the report, it was not reported if the patient recovered from chicken pox. The registered nurse had reported on 2 other students (patients) who were vaccinated with Varivax in the past and recently, in the past few weeks, have had chicken pox. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse practitioner (NP) and registered nurse (RN) concerning a 9-year-old female student with seasonal allergies and allergies to milk, nuts and eggs and no drug allergies who on 19-JAN-1998 was vaccinated SC in the left leg with the first 0.5 mL dose of Varivax (Lot#624447/1419E). There was no illness at the time of vaccination. It was also noted that a dose of MMR II was given at an allergist's office (date no provided). Concomitant therapy included loratadine (CLARITIN) and fluticasone propionate (FLONASE). It was reported that on 01-JUN-2006, the patient was seen in the physician's office with breakthrough chickenpox characterized by a rash with 30 small scattered pustules with an erythematous base mostly on her trunk. No fever or itching was noted. The patient was treated with diphenhydramine hydrochloride (BENADRYL) and oat (AVENO BATH). No laboratory/diagnostic tests were performed. Subsequently, the patient's chickenpox resolved. Additional information is not expected.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature, Rash
Clinical narrative: Information has been received from a person working in a physician's office concerning a 6 year old male who on 31-MAY-2001 was vaccinated with a dose of Varivax. On 22-MAY-2006 the patient experienced a rash on his lower abdomen and penis. It was reported that the patient was afebrile. Subsequently, the patient recovered on 22-MAY-2006. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a woman in a physician's office concerning a 19 month old white male with no allergies or medical history who on 01-NOV-2005 was vaccinated in the left arm with a dose of Varivax (lot # 646536/0550R). There was no illness at the time of vaccination. On an unspecified date, the patient developed chickenpox and subsequently recovered. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative, Drug ineffective
Clinical narrative: Information has been received from a health professional concerning a 35-year-old female who was 'having issues with getting pregnant" who on 23-MAY-2005 and 22-JUN-2005 was vaccinated with the first and second doses of Varivax (Lot # 648087/0099P). It was noted that her lab work showed no immunity for chickenpox. No negative effects were noted. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a student (patient) who in the past was vaccinated with Varivax. Subsequently in the past few weeks, the patient developed chicken pox. It was reported, the patient was in grade one. The patient sought unspecified medical attention. The nurse reported that the physicians have reported this to the state health department. At the time of the report, it was not reported if the patient recovered from chicken pox. The registered nurse had reported on 2 other students (patients) who were vaccinated with Varivax in the past and recently, in the past few weeks, have had chicken pox. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a female patient who on 28-MAY-2003 was vaccinated with a dose of Varivax. On 22-MAY-2006, the patient broke out with a mild case of chickenpox. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 7 year old male, with unknown medical history and unknown drug reactions allergies, who on 19-OCT-2001 was vaccinated (route unknown) with a dose of Varivax (Lot # unknown). On 05-MAY-2006 the patient developed chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a woman in a physician's office concerning a 7 year old female with no allergies or medical conditions who on 04-APR-2000 was vaccinated SC in the left vastus lateralis with a first dose of Varivax (lot # 632042/1360J). Concomitant vaccination on the same day included a SC first dose in the right vastus lateralis of MMR II (lot # 634036/1711J). There was no illness at the time of vaccination. On 16-MAY-2006, the patient broke out with chickenpox lesions and was seen by the physician. No diagnostic laboratory tests were performed. The patient recovered on an unspecified date in May 2006. It was noted that the patient had no adverse events following prior vaccination. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a certified medical assistant (C.M.A.) concerning a male who on 10-JAN-2000 was vaccinated with a dose of Varivax. In January 2006, the patient experienced a chickenpox breakthrough. No medical attention was sought. No outcome was reported. No product quality complaint was involved. Additional information was received on 05-JUL-2006 from the C.M.A. indicating that she is unable to provide any further information because no names were given at the time of the report. No further information is expected.
Age: 48.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a health professional concerning a 49 year old female with no allergies or medical history who on 05-NOV-2004 was vaccinated with a first and second dose of Varivax (lot # 647519/1105N). There was no concomitant medication. On 02-JUN-2006, an antibody titer was checked and the result showed that she had not seroconverted. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Age: 19.0
Sex: M
Vaccine: VARCEL
Symptoms: Folliculitis, Herpes zoster, Rash, Rash pustular, Varicella
Clinical narrative: Information has been received from a physician concerning a 19 year old male with a history of sarcoma and treatment and who has been in remission prior to vaccination who on 14-FEB-2005 and 26-JUL-2005 was vaccinated with a dose of Varivax. He has had two episodes of rash and a culture was negative for varicella zoster virus. Another specimen had been sent to the varicella zoster identification program. The rash was not typical chickenpox but was small and pustular. The physician did not know if it was zoster, chickenpox, or a folliculitis. Information has been received which indicated that the specimen sent for varicella zoster identification was inadequate. Additional information has been requested.
Age: 19.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral test negative
Clinical narrative: Information has been received from a physician concerning a 19 year old male with a history of sarcoma and treatment and who has been in remission prior to vaccination who on 14-FEB-2005 and 26-JUL-2005 was vaccinated with a dose of Varivax. He has had two episodes of rash and a culture was negative for varicella zoster virus. Another specimen had been sent to the varicella zoster identification program. The rash was not typical chickenpox but was small and pustular. The physician did not know if it was zoster, chickenpox, or a folliculitis. Information has been received which indicated that the specimen sent for varicella zoster identification was inadequate. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 6 year old female with no medical history who, at 12 months of age, in approximately 2001, was vaccinated SC with a 0.5 mL dose of Varivax. On 31-MAY-2006, the patient experienced shingles down her right arm. Unspecified medical attention was sought and the patient was given acyclovir and acetaminophen (+) codeine phosphate (TYLENOL WITH CODEINE). No diagnostic laboratory tests were performed. At the time of the report, the patient was getting better. A product quality complaint was not involved.  Follow-up information was received from the physician who reported that she did not believe that this event was an "adverse event." Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Exposure to communicable disease, Pyrexia, Rash, Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 10 year old female with no known medical history or allergies who on 30-APR-1999 was vaccinated with a dose of Varivax (lot # 629257/1851H). Concomitant therapy included Zyrtec and montelukast sodium (MSD). On 04-JUN-2006 the patient developed a fever and rash after being exposed to someone with a shingles infection three weeks ago. There were several lesions but the reporter did not think there were 50 or more. Unspecified medical attention was sought. No laboratory diagnostic tests were performed. The patient's outcome was recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old female who on 18-MAY-2001 was vaccinated with a SC first dose in the right thigh of Varivax (lot # 635465/1468K). There was no illness at the time of vaccination. On 30-MAY-2006 the patient developed a fever and a rash. Unspecified medical attention was sought. Subsequently the patient recovered. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a health professional concerning a 10 year old female who on 18-MAY-2001 was vaccinated in the right thigh with a SC first dose of Varivax (lot # 635465/1468K). There was no illness at the time of vaccination. On 30-MAY-2006 the patient developed a rash and a fever. Subsequently, the patient recovered. Additional information is not expected.
Age: 1.4
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old female who on 30-SEP-2002 was vaccinated in the right thigh with a SC first dose of Varivax (lot # 643084/0472M). There was no illness at the time of vaccination. On 30-MAY-2006 the patient developed a fever and a rash. Subsequently, the patient recovered. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 7 year old female who on 03-FEB-2000 was vaccinated with a dose of Varivax. On 06-JUN-2006 the patient developed a full blown case of chickenpox. Lesion count was not available. Unspecified medical attention was sought. The was no laboratory or diagnostic tests. At the time of the report, the patient's chickenpox. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 6 year old female who on 28-SEP-2000 was vaccinated subcutaneously in the arm with the first dose of Varivax (Lot # 635208/0076K). On 30-MAY-2006 the patient was diagnosed with chickenpox. Subsequently, the patient recovered from the chickenpox. No further information is expected.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Varicella
Clinical narrative: Information has been received from a physician concerning a 3 year old male with no past medical history or drug reactions or allergies, who was vaccinated subcutaneously with only one dose of Varivax (0.5 ml) on 17-JUN-2004 (Lot # 646140/0539N). There was no concomitant medication. On 07-JUN-2006 the patient was diagnosed with a case of breakthrough chickenpox. It was reported that the patient had no known contact with chickenpox and there were greater than 50 poxes. The patient experienced itching, however, had no other problems to date. Unspecified medical attention was sought, and the patient was to be followed by his physician. At the time of this report, the patient was recovering. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old male who was vaccinated with a dose of Varivax. Subsequently the patient broke out with chickenpox. Additional information has been requested. The patient's three brothers experienced chickenpox following vaccination with Varivax (WAES# 0605USA04858, 0606USA01457, 0606USA01458).
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old male who was vaccinated with a dose of Varivax. Subsequently the patient broke out with chickenpox. The patient's 3 brothers experienced chickenpox following vaccination with Varivax (WAES# 0605USA04858, 0606USA01456, 0606USA01458). Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 6 year old male who was vaccinated with a dose of Varivax. Subsequently the patient broke out with chickenpox. Unspecified medical attention was sought. No product quality complaint was involved. The patient's 3 brothers experienced chickenpox following vaccination with Varivax (WAES# 0605USA04858, 0606USA01456, 0606USA01457). Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 11 year old female who on 19-AUG-1996 was vaccinated subcutaneously with 0.5 ml dose of Varivax (Lot #617219/0250D). Concomitant therapy included "DTaP". On 01-JUN-2006, the patient developed full blown varicella rash (more than 50 lesions) after being vaccinated with Varivax. The patient sought unspecified medical attention. At the time of the report, the patient was recovering. The physician also reported that another patient developed full blown varicella rash (more than 50 lesions) after being vaccinated with Varivax (WAES # 0606USA02254). Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash erythematous, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 11 year old female with rhinitis allergic and no known drug allergies who on 27-MAY-1998 was vaccinated with a second dose of Varivax (lot # 625387/0313H). There was no concomitant medications. On 07-JUN-2006 the patient developed 17 fluid filled vesicles and bumps. Unspecified medical attention was sought. Supportive care was recommended. No laboratory diagnostic tests were performed. At the time of the report the patient was recovering. There was no product quality complaint involved. Follow-up information from the registered nurse indicated that the patient was seen on 09-JUN-2006 with a dozen 'or so' red bumps and some vesicles x2 days. There was no complaint of fever or itch. The patient's mother phoned the office on 10-JUN-2006 and started that the spots had all "faded" away, except for one. There was no scabbing and the patient was acting fine. It was unknown if the patient had actual chickenpox. There was no scabbing and the patient was acting fine. It was unknown if the patient had actual chickenpox. There was no illness at the time of vaccination. There were no adverse events following vaccination. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a child who, in the past, was vaccinated with Varivax. In approximately 2005, within the last year, the patient experienced a mild case of breakthrough chickenpox. Subsequently, the patient fully recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Rash papular
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 43-month-old female who on 13-OCT-2003 was vaccinated subcutaneously in the right arm with a dose of Varivax (lot# 645171/0330N). On 31-MAY-2006 the patient developed a rash that progressed with small papules on chest, abdomen, stomach and two on her buttock and a central vesicle. It was noted that several of her papules were larger ones (3-4 mm). It was unspecified if medical attention had been sought. No outcome was reported. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a child who was vaccinated with Varivax. "In the past 2 weeks", in approximately March 2006, the patient experienced breakthrough chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 4-year-old male with no pertinent medical history and no drug reactions/allergies on 29-AUG-2002 was vaccinated with a 0.5mL dose of Varivax (Lot # 641157/0079M). It was unknown if there was an illness at the time of vaccination. Concomitant therapy included a dose of MMR II (Lot # 643499/0538M). There was no other concomitant medication. On 10-JUN-2006 the patient experienced about 30 vesicular lesions, mostly on his trunk. No other symptoms were noted. No other information was available. The outcome was reported as recovering. Unspecified medical attention was sought. There was no product quality complaint involved. There were no relevant diagnostic tests or laboratory data. Follow-up information indicated that on 12-JUN-2006, the patient developed a rash without fever or other symptoms. Approximately 30-35 papules were noted. The outcome was recovered. No additional information is expected.